Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models.
EMBO Mol Med. 2021 Apr 9;13(4):e13144. doi: 10.15252/emmm.202013144. Epub 2021 Mar 4.
EMBO Mol Med. 2021.
PMID: 33660397
Free PMC article.
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor.
Romaniello D, Marrocco I, Belugali Nataraj N, Ferrer I, Drago-Garcia D, Vaknin I, Oren R, Lindzen M, Ghosh S, Kreitman M, Kittel JC, Gaborit N, Bergado Baez G, Sanchez B, Eilam R, Pikarsky E, Paz-Ares L, Yarden Y.
Romaniello D, et al. Among authors: belugali nataraj n.
Cancers (Basel). 2020 Aug 24;12(9):2394. doi: 10.3390/cancers12092394.
Cancers (Basel). 2020.
PMID: 32847130
Free PMC article.
Item in Clipboard
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer.
Noronha A, Belugali Nataraj N, Lee JS, Zhitomirsky B, Oren Y, Oster S, Lindzen M, Mukherjee S, Will R, Ghosh S, Simoni-Nieves A, Verma A, Chatterjee R, Borgoni S, Robinson W, Sinha S, Brandis A, Kerr DL, Wu W, Sekar A, Giri S, Chung Y, Drago-Garcia D, Danysh BP, Lauriola M, Fiorentino M, Ardizzoni A, Oren M, Blakely CM, Ezike J, Wiemann S, Parida L, Bivona TG, Aqeilan RI, Brugge JS, Regev A, Getz G, Ruppin E, Yarden Y.
Noronha A, et al. Among authors: belugali nataraj n.
Cancer Discov. 2022 Nov 2;12(11):2666-2683. doi: 10.1158/2159-8290.CD-22-0111.
Cancer Discov. 2022.
PMID: 35895872
Free PMC article.
Item in Clipboard
Proteomic patterns associated with response to breast cancer neoadjuvant treatment.
Shenoy A, Belugali Nataraj N, Perry G, Loayza Puch F, Nagel R, Marin I, Balint N, Bossel N, Pavlovsky A, Barshack I, Kaufman B, Agami R, Yarden Y, Dadiani M, Geiger T.
Shenoy A, et al. Among authors: belugali nataraj n.
Mol Syst Biol. 2020 Sep;16(9):e9443. doi: 10.15252/msb.20209443.
Mol Syst Biol. 2020.
PMID: 32960509
Free PMC article.
Item in Clipboard
Crosstalk between VEGF and novel angiogenic protein regulates tumor angiogenesis and contributes to aggressiveness of breast carcinoma.
Belugali Nataraj N, Salimath BP.
Belugali Nataraj N, et al.
Cell Signal. 2013 Jan;25(1):277-94. doi: 10.1016/j.cellsig.2012.09.013. Epub 2012 Sep 18.
Cell Signal. 2013.
PMID: 23000338
Item in Clipboard
Cite
Cite